MBRS-16. MYC REGULATED LONG NONCODING RNA LNC-HLX-2–7 IS A PUTATIVE MOLECULAR MARKER AND A THERAPEUTIC TARGET FOR GROUP 3 MEDULLOBLASTOMAS IN CHILDREN
Keisuke Katsushima(Johns Hopkins University), Ranjan J. Perera(Johns Hopkins University), Piyush Joshi(Vanderbilt University), George I. Jallo(Johns Hopkins University), Alexandra Garancher(Sanford Burnham Prebys Medical Discovery Institute), Eric H. Raabe(Johns Hopkins University), Robert J. Wechsler‐Reya(Columbia University Irving Medical Center), Rajeev Vibhakar(Children's Hospital Colorado), Stacie Stapleton(Johns Hopkins University), Charles G. Eberhart(Johns Hopkins University)
Cited by 1
Related Papers
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Medulloblastoma Comprises Four Distinct Molecular Variants
|Journal of Clinical Oncology|2010|1.4k
Intertumoral Heterogeneity within Medulloblastoma Subgroups
|Cancer Cell|2017|1.3k
Altered Telomeres in Tumors with <i>ATRX</i> and <i>DAXX</i> Mutations
|Science|2011|1.1k
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma
|Nature Medicine|2015|711